Header Logo

Connection

MICHAEL R MIGDEN to Australia

Back to Details
This is a "connection" page, showing publications MICHAEL R MIGDEN has written about Australia.
MICHAEL R MIGDEN
Connection Strength
0.166
Australia
  1. Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial. Lancet Oncol. 2020 02; 21(2):294-305.
    View in: PubMed
    Score: 0.166
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.